Latest filing published 16 Mar 2026 for Surgery Partners, Inc., €39k.
Danielle Burkhalter discloses dealings in Surgery Partners, Inc. to SEC (Form 4). In total, 26 filings cover trades dated from 31 January 2023 to 13 March 2026.
No open-market purchase appears, only 16 sales worth €387k. Besides market trades, the filings include 10 share grants. Since January 2026: no purchases and 2 sales on the market.
The latest filing, published on 16 March 2026, reports an open-market sale of €39k in Surgery Partners, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations